Cargando…

Bone Marrow-Derived Mesenchymal Stem Cells Modified with Akt1 Ameliorates Acute Liver GVHD

BACKGROUND: Liver injury associated with acute graft-versus-host disease (aGVHD) is a frequent and severe complication of hematopoietic stem cell transplantation and remains a major cause of transplant-related mortality. Bone marrow-derived mesenchymal stem cells (BM-MSCs) has been proposed as a pot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Lukun, Liu, Shuang, Wang, Zhao, Yao, Jianfeng, Cao, Wenbin, Chen, Shulian, Xie, Wenjun, Feng, Shuqing, Xu, Yuanfu, Cheng, Tao, Han, Mingzhe, Feng, Sizhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913026/ https://www.ncbi.nlm.nih.gov/pubmed/31889917 http://dx.doi.org/10.1186/s12575-019-0112-2

Ejemplares similares

Chronic GVHD: predictive factor for rhinosinusitis in bone marrow transplantation
por: Ortiz, Erica, et al.
Publicado: (2015)

CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia
por: Lu, Shihong, et al.
Publicado: (2017)

Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
por: Szyska, Martin, et al.
Publicado: (2016)

Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?
por: Introna, Martino, et al.
Publicado: (2020)

Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure
por: Stenger, Elizabeth O., et al.
Publicado: (2023)

The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients
por: Zeng, Defu
Publicado: (2023)

Extracellular Acidification Acts as a Key Modulator of Neutrophil Apoptosis and Functions
por: Cao, Shannan, et al.
Publicado: (2015)

Correction: Extracellular Acidification Acts as a Key Modulator of Neutrophil Apoptosis and Functions
por: Cao, Shannan, et al.
Publicado: (2015)

Bone marrow-derived mesenchymal stem cell-conditioned medium ameliorates diabetic foot ulcers in rats
por: Xu, Yi-Feng, et al.
Publicado: (2023)

PB2411: THE EFFICACY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR AUTOLOGOUS-HSCT IN LOW-RISK AND INTERMEDIATE-RISK AML PATIENTS
por: Zhai, Weihua, et al.
Publicado: (2023)

Inositol pyrophosphates mediate the effects of aging on bone marrow mesenchymal stem cells by inhibiting Akt signaling
por: Zhang, Zheng, et al.
Publicado: (2014)

The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice
Publicado: (1996)

Modulating endothelial cells with EGFL7 to diminish aGVHD after allogeneic bone marrow transplantation in mice
por: Dorrance, Adrienne M., et al.
Publicado: (2022)

Mesenchymal stromal cells ameliorate chronic GVHD by boosting thymic regeneration in a CCR9-dependent manner in mice
por: Zhang, Xin, et al.
Publicado: (2023)

Colon biopsies for evaluation of acute graft-versus-host disease (A-GVHD) in allogeneic bone marrow transplant patients
por: Shidham, Vinod B, et al.
Publicado: (2003)

Donor bone marrow–derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice
por: Adams, Rachael C., et al.
Publicado: (2022)

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
por: Weng, J Y, et al.
Publicado: (2010)

Regulatory T Cells in GVHD Therapy
por: Guo, Wen-wen, et al.
Publicado: (2021)

Metformin Ameliorates D-Galactose-Induced Senescent Human Bone Marrow-Derived Mesenchymal Stem Cells by Enhancing Autophagy
por: Ye, Pingting, et al.
Publicado: (2023)

Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome
por: Li, Xiaoqing, et al.
Publicado: (2020)

Directional homing of glycosylation-modified bone marrow mesenchymal stem cells for bone defect repair
por: Chen, Long, et al.
Publicado: (2021)

Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant
por: SONG, NINGXIA, et al.
Publicado: (2015)

CD11c participates in triggering acute graft‐versus‐host disease during bone marrow transplantation
por: Wang, Qianqian, et al.
Publicado: (2021)

Donor Bone Marrow-Derived T Cells Inhibit GVHD Induced by Donor Lymphocyte Infusion in Established Mixed Allogeneic Hematopoietic Chimeras
por: Wang, Hui, et al.
Publicado: (2012)

Impaired thymic iNKT cell differentiation at early precursor stage in murine haploidentical bone marrow transplantation with GvHD
por: Zhao, Weijia, et al.
Publicado: (2023)

GVHD-derived plasma as a priming strategy of mesenchymal stem cells
por: Silva-Carvalho, Amandda Évelin, et al.
Publicado: (2020)

miR-204–containing exosomes ameliorate GVHD-associated dry eye disease
por: Zhou, Tian, et al.
Publicado: (2022)

Amelioration of aflatoxin acute hepatitis rat model by bone marrow mesenchymal stem cells and their hepatogenic differentiation
por: Abo-Aziza, Faten A. M., et al.
Publicado: (2022)

Bone Marrow Mesenchymal Stem-Cell-Derived Exosomes Ameliorate Deoxynivalenol-Induced Mice Liver Damage
por: Meng, Zitong, et al.
Publicado: (2023)

Brain-derived neurotrophic factor gene-modified bone marrow mesenchymal stem cells
por: HAN, ZHONG-MIN, et al.
Publicado: (2015)

GVHD Prophylaxis 2020
por: Gooptu, Mahasweta, et al.
Publicado: (2021)

Transplantation of IL-1β siRNA-modified bone marrow mesenchymal stem cells ameliorates type II collagen-induced rheumatoid arthritis in rats
por: Pan, Shifeng, et al.
Publicado: (2022)

Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway
por: Xie, C, et al.
Publicado: (2013)

Mucosal-associated invariant T cells predict increased acute graft-versus-host-disease incidence in patients receiving allogeneic hematopoietic stem cell transplantation
por: Wang, Zhao, et al.
Publicado: (2022)

Sirolimus-Based Immunosuppression as GvHD Prophylaxis after Bone Marrow Transplantation for Severe Aplastic Anaemia: A Case Report and Review of the Literature
por: Perruccio, Katia, et al.
Publicado: (2015)

Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity
por: Ding, Li, et al.
Publicado: (2020)

Optic neuropathy associated with GVHD after bone marrow allogeneic hematopoietic stem cell transplantation for B-Acute lymphoblastic leukemia: case report
por: Wang, Bowen, et al.
Publicado: (2022)

Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice
por: Wu, Yongxia, et al.
Publicado: (2021)

JAK1/2 inhibitor ruxolitinib promotes the expansion and suppressive action of polymorphonuclear myeloid‐derived suppressor cells via the JAK/STAT and ROS‐MAPK/NF‐κB signalling pathways in acute graft‐versus‐host disease
por: Cao, Yigeng, et al.
Publicado: (2023)

Bacteria-Induced Acute Inflammation Does Not Reduce the Long-Term Reconstitution Capacity of Bone Marrow Hematopoietic Stem Cells
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tirtejunspilbadvohu1oh52l4